Burtis W J, Fodero J P, Gaich G, Debeyssey M, Stewart A F
Division of Endocrinology, West Haven VA Medical Center, Connecticut 06516.
J Clin Endocrinol Metab. 1992 Oct;75(4):1110-4. doi: 10.1210/jcem.75.4.1400879.
PTH-related peptide (PTHrP) immunoreactivity in plasma from six well characterized patients with humoral hypercalcemia of malignancy was characterized by gel filtration chromatography. An immunoradiometric assay directed against the N-terminal 74 amino acids of PTHrP and a RIA directed against the C-terminal region (amino acids 109-138) of the peptide were used to assay column fractions. When examined using acid (pH 5.0) nondenaturing conditions, N-terminal PTHrP immunoreactivity eluted with an apparent M(r) of 30,000-40,000. The apparent M(r) of this PTHrP fragment shifted to approximately 25,000 when gel filtration was performed at pH 9.0. The apparent M(r) shifted further, to approximately 6,500, when chromatographed under denaturing conditions in 4 M guanidine-HCl. Carboxy-terminal PTHrP immunoreactivity in plasma eluted with an M(r) of approximately 12,000 under acid nondenaturing conditions, as did the synthetic C-terminal PTHrP column marker, PTHrP (109-138). Synthetic PTHrP (1-36) and (1-74), and recombinant PTHrP (1-141) as well as native PTHrP species found in milk and keratinocyte-conditioned medium migrated in their expected positions when analyzed under alkaline nondenaturing or under denaturing condition. We conclude that native, synthetic, and recombinant PTHrP peptides may migrate anomalously when examined using gel filtration under nondenaturing conditions, and such studies should be interpreted with caution. Plasma from patients with humoral hypercalcemia of malignancy contains at least two PTHrP species. One native N-terminal fragment appears, as assessed under denaturing conditions, to have an M(r) of approximately 6,500, and to therefore comprise approximately 50-60 amino acids of full-length PTHrP. A second chromatographically and immunologically distinct C-terminal fragment with an M(r) of approximately 12,000 under nondenaturing conditions is also present.
采用凝胶过滤色谱法对6例特征明确的恶性肿瘤体液性高钙血症患者血浆中的甲状旁腺激素相关肽(PTHrP)免疫反应性进行了分析。采用针对PTHrP N端74个氨基酸的免疫放射分析和针对该肽C端区域(氨基酸109 - 138)的放射免疫分析来检测柱分离组分。在酸性(pH 5.0)非变性条件下进行检测时,N端PTHrP免疫反应性以表观分子量(M(r))30,000 - 40,000洗脱。当在pH 9.0条件下进行凝胶过滤时,该PTHrP片段的表观M(r)移至约25,000。在4M盐酸胍变性条件下进行色谱分析时,表观M(r)进一步移至约6,500。在酸性非变性条件下,血浆中的C端PTHrP免疫反应性以M(r)约12,000洗脱,合成的C端PTHrP柱标记物PTHrP(109 - 138)也是如此。在碱性非变性或变性条件下分析时,合成的PTHrP(1 - 36)和(1 - 74)、重组PTHrP(1 - 141)以及在牛奶和角质形成细胞条件培养基中发现的天然PTHrP在其预期位置迁移。我们得出结论,在非变性条件下使用凝胶过滤进行检测时,天然、合成和重组的PTHrP肽可能会异常迁移,此类研究应谨慎解读。恶性肿瘤体液性高钙血症患者的血浆中至少含有两种PTHrP。在变性条件下评估,一种天然N端片段的表观M(r)约为6,500,因此全长PTHrP约含50 - 60个氨基酸。还存在第二种在非变性条件下M(r)约为12,000的色谱和免疫特性不同的C端片段。